Skip to main content
. 2021 Apr 29;12:667804. doi: 10.3389/fneur.2021.667804

Table 1.

Vertigo group (n = 29) Non-vertigo group (n = 21) P-value
Age (years) 55.93 ± 14.15 50.86 ± 15.81 0.240
Sex 0.077
   Male % (n) 41.4 (12) 66.7 (14)
   Female % (n) 58.6 (17) 33.3 (7)
Affected side 0.774
   Center % (n) 48.3 (14) 52.4 (11)
   Right % (n) 51.7 (15) 47.6 (10)
Abnormal HSC % (n) 6.9 (2) 14.3 (3) 0.638
Abnormal ASC % (n) 34.5 (10) 33.3 (7) 0.933
Abnormal PSC % (n) 58.6 (17) 28.6 (6) 0.035*
Abnormal cVEMP % (n) 75.9 (22) 61.9 (13) 0.288
Abnormal oVEMP % (n) 82.8 (24) 57.1 (12) 0.046*
Number of involved vestibular end organs 2.55 ± 1.40 1.76 ± 1.34 0.093
Initial PTA (dB) 84.58 ± 20.22 72.01 ± 20.55 0.007**
Final PTA (dB) 76.41 ± 22.94 52.24 ± 30.93 0.006**
Audiogram configuration % (n) 0.019*
Low-frequency hearing loss 3.4 (1) 14.3 (3)
High-frequency hearing loss 3.4 (1) 9.5 (2)
Flat-type hearing loss 6.9 (2) 28.6 (6)
Profound hearing loss 86.2 (25) 47.6 (10)
Hearing recovery % (n) 0.558
Complete recovery 6.9 (2) 14.3 (3)
Partial recovery 13.8 (4) 23.8 (5)
Slight recovery 13.8 (4) 14.3 (3)
No response 65.5 (19) 47.6 (10)

Continuous data are presented as mean ± SD values; categorical data are reported as percentage (number). The asterisk indicates statistical significance between groups (*p < 0.05, **p < 0.01).

HSC, horizontal semicircular canal; ASC, anterior semicircular canal; PSC, posterior semicircular canal; cVEMP, cervical vestibular-evoked myogenic potential; oVEMP, ocular vestibular-evoked myogenic potential; PTA, pure-tone average.